JUSTIN GRIFKA: Open Payments
NPI 1548652860 · AUBURN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 74 payments from 14 companies in 2025. Trend: 2023 $845 · 2024 $1,236 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $316 |
| AstraZeneca Pharmaceuticals LP | 12 | $261 |
| Novo Nordisk Inc | 11 | $202 |
| Lilly USA, LLC | 8 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| PFIZER INC. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Exact Sciences Corporation | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
Products named: AIRSUPRA, QULIPTA, UBRELVY, Kerendia, MOUNJARO, ELIQUIS, Ozempic, Rybelsus.
Industry payments across MI — which companies pay providers there.
